▲ Peaking
Health
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Eli Lilly’s CEO outlines how GLP-1 drugs could redefine obesity treatment—and America’s health economy—amid new oral breakthroughs.
3 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly’s CEO outlines how GLP-1 drugs could redefine obesity treatment—and America’s health economy—amid new oral breakthroughs.
Parents of elementary-age children are increasingly turning to GLP-1 drugs like Wegovy as obesity interventions
Emerging research links GLP-1 weight-loss medications to potential improvements in male fertility, including increased testosterone and sperm counts.